What question did this study set out to answer?

This research aims to evaluate the impact of intravenous immunoglobulin (IVIG) on infection rates in chronic lymphocytic leukemia (CLL) patients.

May 8, 2026Cancer Research CommunicationsOpen Access

Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis

View Full Paper

Ask AI

Bookmark

Authors

NSNirja N. ShahUC San Diego Health System TPTulsi PatelUC San Diego Health System TKT J KippsSanford Burnham Prebys Medical Discovery Institute

Discussion

Member takes

Implication

Retrospective analysis shows that IVIG significantly reduces infections in chronic lymphocytic leukemia patients, suggesting improved quality of life.

Key Points

This research aims to evaluate the impact of intravenous immunoglobulin (IVIG) on infection rates in chronic lymphocytic leukemia (CLL) patients.
Single-center retrospective cohort study involving 52 CLL patients who received IVIG.
Inclusion criteria: history of hypogammaglobulinemia and recurrent infections, with a focus on infections prior to and after IVIG initiation.
Analysis of infectious outcomes between 2005 and 2022, totaling a 12-month follow-up post-IVIG.
IVIG was associated with a 67% reduction in risk of grade ≥ 2 infections (RR 0.33, 95% CI 0.22 – 0.48; p < 0.0001).
Only 17 patients (33%) had a grade ≥ 2 infection in the year following IVIG compared to all patients pre-treatment.
The mean number of infections per patient decreased from 2.1 to 0.4 after IVIG treatment.

Cite This Study

Shah et al. (2026) studied this question.

synapsesocial.com/papers/69fd7e5cbfa21ec5bbf069d5 https://doi.org/10.1158/2767-9764.crc-26-0177

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis shows that IVIG significantly reduces infections in chronic lymphocytic leukemia patients, suggesting improved quality of life.

Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider